Purchase Order 75N92023P00311
Award Date
8/24/23
Potential Completion Date
8/24/24
Potential Value
$224K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Cell Signaling Technology, Inc.
Ultimate Awardee
Not listed
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Danvers, MA 01923, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $34,653 purchase order to Sigma-Aldrich, Inc. to deliver a CELLASIC ONIX2 MICROFLUIDIC SYSTEM FOR LIVE CELL STUDIES. The firm fixed price contract has a period of performance from July 26, 2023 through September 25, 2023 for the microfluidic system to be utilized at the prime contractor's place of performance in St. Louis, Missouri. No subcontractors or set aside...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $35,041.80 firm fixed price delivery order to Illumina, Inc. to provide Illumina kits and reagents in support of next-generation sequencing activities on Illumina instruments for Institute-funded investigators. The sequencing core facility at the NHLBI requires the products from Illumina to carry out its mission of performing next-generation sequencing on Illumina...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...
The National Heart Lung and Blood Institute (NHLBI) awarded a firm-fixed-price purchase order contract to Seahorse Bioscience, Inc. (Seahorse Labware) for an Extracellular Flux Analyzer. The $161,745.00 contract has a completion date of September 13, 2016 and was set aside for small businesses. The contract is not associated with a larger vehicle. The NHLBI is a component of the U.S. Department of Health and Human Services that conducts research to prevent and treat heart, lung, blood, and sleep...
The National Heart, Lung and Blood Institute of the National Institutes of Health awarded a $16,319.69 firm fixed price delivery order to Fisher Scientific Company L.L.C. under the company's Multiple Award Schedule contract with the General Services Administration. The delivery order is to provide a Milli-Q IQ 7000 purification system to the Laboratory of Cell and Tissue Morphodynamics as part of the Center for the Developmental and Perinatal Cardiology of the NHLBI. The period of performance is...
The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, awarded a time and materials contract to Medical Science & Computing, LLC, a for-profit limited liability company. The $174,577.20 contract is a call under the NHLBI's Blanket Purchase Agreement for the services of a pulmonary function technician to support pediatric, adult, and geriatric patient care. This award is not a...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $190,250.40 purchase order to Agilent Technologies Inc. Customer Service And Sales Division for a live-cell metabolic analyzer. The contract has a period of performance from September 20, 2023 through September 19, 2024 and utilizes a firm fixed price structure. Per the original solicitation, the prime contractor will deliver a live-cell metabolic analyzer to support the...